Clinical Trial Update: Treating Peritoneal Carcinomatosis With PIPAC [Phase 2]

View source ↗

Summary

Phase 2 trial update on treating peritoneal carcinomatosis with PIPAC has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Snippet

Sponsor: Michael Bau Mortensen | Conditions: Peritoneal Carcinomatosis | Phase 2 | Status: COMPLETED